
From the April 2025 ADVENT Forum in Lisbon, Portugal, this event page serves to spotlight curated soundbites from dermatology and immunology experts that connect the evolving science of type 2 inflammation to clinical application.

Professor Alberto Papi presents the latest clinical data on current and emerging biologics for COPD with type 2 inflammation.

This symposium illustrated the ways type 2inflammation contributes to atopic dermatitis (AD) disease pathogenesis within and beyond the skin, discussed the importance of early intervention in children with AD, and explored the potential for disease modification. The program concluded with a review of the latest clinical and real-world data on advanced systemic treatments for children with AD.

This video clip from the EAACI 2024 symposium discusses whether patients with CRSwNP should undergo a surgery.
This infographic explores the emerging concepts of disease activity, disease stability, and disease control in COPD.
Join Dr. Sarina Elmariah as she discusses the challenges in diagnosing prurigo nodularis.